The money raised will be used to further explore more possibilities for using computer science to empower innovations in the life sciences sector.
Digital therapy
Aurora, a technology company specializing in the digitalization of the clinical research of life sciences, recently complete a Series A+ financing round worth tens of millions of USD.
The round was led by the existing investor Hankang Equity Investment Management, with participation from B Capital. Huaxing Capital acted as its exclusive financial advisor.
Founded in 2020 in Shanghai, China, Aurora focuses on the field of life science clinical research and development, and is committed to creating a world-leading new generation of clinical research SaaS platform, with cloud computing, big data, AI, enterprise-level B2B SaaS technology, thereby reducing costs and increasing efficiency. Aurora's team members are mainly from Google, Verily, Splunk, Medidata, Veeva, WuXi AppTec and other global leading companies in related fields.
The Billion-Dollar European Caviar Business, Now Disrupted by China
Nov 08, 2024 01:52 PM
Forty Years of Striving: How Globalization Has Shaped Lenovo Today?
Nov 07, 2024 06:51 PM